Top Markets
#1 DogBull DogBull +53.26%
#2 OriginTrail OriginTrail +16.86%
#3 龙虾 (Lobster) 龙虾 (Lobster) +10.64%
#4 Siren Siren +10.53%
#5 Verus Coin Verus Coin +8.62%
#6 COTI COTI +7.40%
#7 Tutorial Tutorial +7.07%
#8 Stargate Finance Stargate Finance +7.05%
#9 PulseChain PulseChain +6.89%
#10 Yield Basis Yield Basis +6.63%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Pozycja w akcjach #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Cena akcji
$2.23
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$95.23M
Zmiana (1 dzień)
1.14%
Zmiana (1 rok)
63.60%
Kraj
US
Handel Acrivon Therapeutics, Inc. Common Stock (ACRV)

Kategoria

Healthcare
Historia ceny akcji dla Acrivon Therapeutics, Inc. Common Stock (ACRV)
Najwyższa cena zamknięcia: $1.94 dnia 2026-08-01

Najniższa cena zamknięcia: $13.89 dnia 2022-11-01
Historia cen akcji firmy Acrivon Therapeutics, Inc. Common Stock od 2022 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -23.66%
2025 -63.95%
2024 34.00%
2023 -58.79%
2022 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH